Develops transcatheter smart implants that autonomously monitor and modulate heart function to improve outcomes in heart failure patients.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Relief Cardiovascular develops transcatheter smart implant systems designed to enhance volume management in heart failure patients. The company’s flagship product, the Relief System, is the world’s first transcatheter preload modulating implant that enables autonomous hemodynamic monitoring and venous return modulation to improve outcomes for those with congestive heart failure.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Relief Cardiovascular Management Team
Investors
Advent Life Sciences
Relief Cardiovascular Valuations & Financials
View real-time NPM data on Relief Cardiovascular stock including daily Relief Cardiovascular stock price estimates, valuation history, and historical share price information. Access Relief Cardiovascular financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Relief Cardiovascular pricing across six independent market signals. Looking for private company due diligence data sources on Relief Cardiovascular? Get in touch to learn more.
Similar Companies
like Relief Cardiovascular
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Obvio
AI & Machine Learning
Detects unsafe driving via smart cameras to provide insight and enable automated enforcement for safer streets.
Zivian Health
Healthcare & Life Sciences
Automates regulatory tracking and physician matching to streamline clinical collaborations for advanced practice healthcare teams.
Actio Biosciences
Healthcare & Life Sciences
Advances therapies which target genetic drivers in rare and common diseases via a precision‑medicine platform.
Worldia
Enterprise Software
Digital platform enabling travel agencies to create and book customized trips with real-time rates for transportation, activities and accommodations.
Team Health Holdings
Healthcare & Life Sciences
Delivers physician-led clinical and operational services across a full spectrum of hospital and post-acute care settings.
Leash Biosciences
Healthcare & Life Sciences
Helps research teams manage and execute experimental workflows with collaborative tools and automated data capture.
Hyperexponential
FinTech
Develops pricing intelligence software for insurers to optimize underwriting decisions and build pricing models through advanced analytics.
FAQ
We have answers
Relief Cardiovascular stock does not trade on public stock exchanges. Relief Cardiovascular stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Relief Cardiovascular stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Relief Cardiovascular Stock does not trade on public stock exchanges. In order to sell Relief Cardiovascular shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Relief Cardiovascular does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Relief Cardiovascular share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Relief Cardiovascular stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Relief Cardiovascular stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Relief Cardiovascular stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Relief Cardiovascular is a private company and has not had an IPO. There is currently no Relief Cardiovascular IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Relief Cardiovascular IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
